Company / Operating Margin
Clearside Biomedical, Inc. Operating Margin History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1735.7%
FY2024
5-year range
-2281.6% / -2.1%
FY2020-FY2024
Trend
-474.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -475% YoY in FY2024, a notable deviation from the 6-year average annual change of -17938%.
Based on SEC 10-K filings.
-1735.7% in FY2024 with a 5-year CAGR of -341.1%.
Improved from -2281.6% to -1735.7% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -1733.6pp
- 5-Year Change
- -341.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin decreased 474.7% year-over-year.
- Peak operating margin was recorded in FY2021.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -1735.7% | -474.7% |
| FY2023 | -302.0% | +86.8% |
| FY2022 | -2281.6% | -107523.1% |
| FY2021 | -2.1% | +99.1% |
| FY2020 | -227.2% | +83.7% |
| FY2019 | -1394.6% | +99.5% |
| FY2018 | -276483.3% | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026